Post-Exercise Recovery
Conditions
Interventions
This is a three-arm, double-blind, randomized controlled clinical trial. It will involve 33 physically active volunteers (11 per group), aged between 18 and 35, who will be randomly assigned to three
E01.370.600.425
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal do Rio Grande do Norte
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Men aged between 18 and 35 years; classified as physically active according to the International Physical Activity Questionnaire (IPAQ) classification; who do not perform regular jumping training; who have not used Intermittent Pneumatic Compression prior to this research
Exclusion criteria
Exclusion criteria: Subjects with musculoskeletal injuries or lower limb surgeries within a period of nine months prior to the tests; with an inflammatory rheumatological condition or severe cardiovascular and/or pulmonary disease that prevents them from performing the proposed assessment and tests; with any condition that is contraindicated for performing maximum strength tests
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle Pain will be assessed using a 100mm visual analogue scale. Muscle pain will be assessed at all assessment times, and a difference of at least 20% is expected to be considered a clinically relevant change | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuromuscular performance will be assessed using isokinetic and isometric tests, performed on the Biodex Multi-Joint System 3 isokinetic dynamometer. The isometric performance of knee extensors will be assessed, with the knee flexed at 60º, and the isokinetic performance of knee flexion-extension at a speed of 60º/s;Functional Performance will be assessed using the single-leg vertical jump test with countermovement. Each volunteer will perform a total of three jumps with each limb, and the average of the values ??will be analyzed;Perceived Fatigue will be assessed using a visual analogue scale at all assessment times;The level of Perception of Recovery will be assessed using the total quality of recovery scale, only in the assessments 24 and 48 hours after the intervention;The Global Perception of the Effect of Treatment will be assessed in the last evaluation, using a five-point Likert scale;Biochemical markers of muscle damage will be assessed through serum creatine kinase levels. 5 ml of venous blood will be collected at each assessment time for analysis | — |
Countries
Brazil
Contacts
Public ContactCosme Aquino Neto
Universidade Federal do Rio Grande do Norte
Outcome results
None listed